Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 25, 2023. (Total: 221440Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Neoplasms and meta-analysis and CYP2D6[original query]
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis.
Breast cancer research and treatment 2010 Aug 122 (3): 609-17.
Seruga Bostjan, Amir Eit
Genetic variants of CYP2D6 gene and cancer risk: a HuGE systematic review and meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (7): 3165-72.
Zhou Li-Ping, Luan Hong, Dong Xi-Hua, Jin Guo-Jiang, Man Dong-Liang, Shang Ho
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clinical pharmacology and therapeutics 2014 Feb 95 (2): 216-27.
Province M A, Goetz M P, Brauch H, Flockhart D A, Hebert J M, Whaley R, Suman V J, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman W G, Lee M-T M, Ambrosone C B, Beckmann M W, Choi J-Y, Dieudonné A-S, Fasching P A, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan L B, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen A T, Park B-W, Purdie C A, Quinlan P, Renner W, Schmidt M, Schwab M, Shin J-G, Stingl J C, Wegman P, Wingren S, Wu A H B, Ziv E, Zirpoli G, Thompson A M, Jordan V C, Nakamura Y, Altman R B, Ames M M, Weinshilboum R M, Eichelbaum M, Ingle J N, Klein T E,
CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis.
Cancer chemotherapy and pharmacology 2013 Aug 72 (2): 287-303.
Zeng Zhiyu, Liu Yanqiong, Liu Zhiming, You Jianpeng, Chen Zhiping, Wang Jian, Peng Qiliu, Xie Li, Li Ruolin, Li Shan, Qin X
CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Aug 34 (4): 2189-93.
Huang Yan, Liu Xin, Kuang Xin, Liao Duanfa
Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis.
Pharmacogenomics 2014 Jan 15 (1): 49-60.
Jung Jin-A, Lim Hyeong-Se
CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.
PloS one 2013 8 (10): e76648.
Lum Danny W K, Perel Pablo, Hingorani Aroon D, Holmes Michael
A Simulation Study to Compare the Treatment Effect of Tamoxifen by CYP2D6 Genotypes and Third-Generation Aromatase Inhibitors.
Journal of clinical pharmacology 2017 Apr .
Park Gwan Cheol, Jung Jin-A, Bae Kyun-Seop, Lim Hyeong-Se
The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.
OncoTargets and therapy 2017 10 5429-5437.
Lu Junjun, Li He, Guo Peng, Shen Rui, Luo Yingbin, Ge Qiao, Shi Wenfei, Li Yan, Zhu Weika
Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis.
Cancer chemotherapy and pharmacology 2019 Jan 83 (1): 71-79.
Bai Yu, Wu Hai-Wei, Zhang Yan-H
TOP